IMMUNOME INC (IMNM) Stock Fundamental Analysis

NASDAQ:IMNM • US45257U1088

21.5 USD
-0.64 (-2.89%)
At close: Feb 20, 2026
21.6888 USD
+0.19 (+0.88%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IMNM. IMNM was compared to 521 industry peers in the Biotechnology industry. IMNM has a great financial health rating, but its profitability evaluates not so good. IMNM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year IMNM has reported negative net income.
  • In the past year IMNM has reported a negative cash flow from operations.
  • IMNM had negative earnings in each of the past 5 years.
  • In the past 5 years IMNM always reported negative operating cash flow.
IMNM Yearly Net Income VS EBIT VS OCF VS FCFIMNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

  • IMNM's Return On Assets of -74.40% is on the low side compared to the rest of the industry. IMNM is outperformed by 64.49% of its industry peers.
  • The Return On Equity of IMNM (-84.40%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -74.4%
ROE -84.4%
ROIC N/A
ROA(3y)-116.62%
ROA(5y)-86.52%
ROE(3y)-158.72%
ROE(5y)-114.11%
ROIC(3y)N/A
ROIC(5y)N/A
IMNM Yearly ROA, ROE, ROICIMNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

  • IMNM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMNM Yearly Profit, Operating, Gross MarginsIMNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • IMNM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IMNM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, IMNM has more shares outstanding
  • There is no outstanding debt for IMNM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMNM Yearly Shares OutstandingIMNM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMNM Yearly Total Debt VS Total AssetsIMNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • IMNM has an Altman-Z score of 35.81. This indicates that IMNM is financially healthy and has little risk of bankruptcy at the moment.
  • IMNM has a better Altman-Z score (35.81) than 93.67% of its industry peers.
  • There is no outstanding debt for IMNM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 35.81
ROIC/WACCN/A
WACC8.72%
IMNM Yearly LT Debt VS Equity VS FCFIMNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

  • IMNM has a Current Ratio of 8.90. This indicates that IMNM is financially healthy and has no problem in meeting its short term obligations.
  • IMNM has a better Current ratio (8.90) than 78.50% of its industry peers.
  • IMNM has a Quick Ratio of 8.90. This indicates that IMNM is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of IMNM (8.90) is better than 78.50% of its industry peers.
Industry RankSector Rank
Current Ratio 8.9
Quick Ratio 8.9
IMNM Yearly Current Assets VS Current LiabilitesIMNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.63% over the past year.
  • IMNM shows a decrease in Revenue. In the last year, the revenue decreased by -4.44%.
EPS 1Y (TTM)63.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-4.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • IMNM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.24% yearly.
  • The Revenue is expected to grow by 105.98% on average over the next years. This is a very strong growth
EPS Next Y55.17%
EPS Next 2Y21.76%
EPS Next 3Y15.82%
EPS Next 5Y16.24%
Revenue Next Year-23.19%
Revenue Next 2Y-7.45%
Revenue Next 3Y104.57%
Revenue Next 5Y105.98%

3.3 Evolution

IMNM Yearly Revenue VS EstimatesIMNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
IMNM Yearly EPS VS EstimatesIMNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IMNM. In the last year negative earnings were reported.
  • Also next year IMNM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMNM Price Earnings VS Forward Price EarningsIMNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMNM Per share dataIMNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IMNM's earnings are expected to grow with 15.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.76%
EPS Next 3Y15.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IMNM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMMUNOME INC

NASDAQ:IMNM (2/20/2026, 8:00:01 PM)

After market: 21.6888 +0.19 (+0.88%)

21.5

-0.64 (-2.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners82.16%
Inst Owner Change14.04%
Ins Owners1.22%
Ins Owner Change-3.13%
Market Cap2.37B
Revenue(TTM)9.68M
Net Income(TTM)-222.74M
Analysts85.26
Price Target35.14 (63.44%)
Short Float %15.49%
Short Ratio6.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.83%
Min EPS beat(2)-10.97%
Max EPS beat(2)7.32%
EPS beat(4)2
Avg EPS beat(4)-23.83%
Min EPS beat(4)-116.8%
Max EPS beat(4)25.15%
EPS beat(8)2
Avg EPS beat(8)-224.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)175.54%
Min Revenue beat(2)-100%
Max Revenue beat(2)451.08%
Revenue beat(4)2
Avg Revenue beat(4)310.04%
Min Revenue beat(4)-100%
Max Revenue beat(4)904.04%
Revenue beat(8)4
Avg Revenue beat(8)160.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)43.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-64.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 245.08
P/FCF N/A
P/OCF N/A
P/B 8.99
P/tB 8.99
EV/EBITDA N/A
EPS(TTM)-2.95
EYN/A
EPS(NY)-2.67
Fwd EYN/A
FCF(TTM)-1.8
FCFYN/A
OCF(TTM)-1.68
OCFYN/A
SpS0.09
BVpS2.39
TBVpS2.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -74.4%
ROE -84.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-116.62%
ROA(5y)-86.52%
ROE(3y)-158.72%
ROE(5y)-114.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 701.48%
Cap/Sales 137.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.9
Quick Ratio 8.9
Altman-Z 35.81
F-Score5
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)1218.68%
Cap/Depr(5y)748.84%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y55.17%
EPS Next 2Y21.76%
EPS Next 3Y15.82%
EPS Next 5Y16.24%
Revenue 1Y (TTM)-4.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-23.19%
Revenue Next 2Y-7.45%
Revenue Next 3Y104.57%
Revenue Next 5Y105.98%
EBIT growth 1Y-85.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.81%
EBIT Next 3Y2.63%
EBIT Next 5YN/A
FCF growth 1Y-7556.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5864.05%
OCF growth 3YN/A
OCF growth 5YN/A

IMMUNOME INC / IMNM FAQ

What is the ChartMill fundamental rating of IMMUNOME INC (IMNM) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMNM.


What is the valuation status of IMMUNOME INC (IMNM) stock?

ChartMill assigns a valuation rating of 0 / 10 to IMMUNOME INC (IMNM). This can be considered as Overvalued.


What is the profitability of IMNM stock?

IMMUNOME INC (IMNM) has a profitability rating of 0 / 10.


What is the financial health of IMMUNOME INC (IMNM) stock?

The financial health rating of IMMUNOME INC (IMNM) is 8 / 10.